Process for the humanization of animal skim milk and products obtained thereby

Patent metadata

Field	Value
Publication number	US-10772339-B2
Application number	US-201214384654-A
Country	US
Kind code	B2
Filing date	Mar 12, 2012
Priority date	Mar 12, 2012
Publication date	Sep 15, 2020
Grant date	Sep 15, 2020

Abstract

The invention relates to a process for the treatment of animal skim milk and for the production of an infant formula base product from animal skim milk, which process is highly efficient and cost effective, as only membrane filtration techniques, such as microfiltration and ultrafiltration, are required. By carefully controlling the process parameters, a product is obtained in which most of the major components are within the desired range for an infant formula base product. The invention also relates to products obtainable by the process according to the invention.

First claim

The invention claimed is:

1. A process for the preparation of an infant formula, comprising:
(a) microfiltering animal skim milk over (i) a ceramic membrane having a porosity of 0.10-0.30 micrometer at a volume concentration factor of 5-7 and temperature between 40° C. and 70° C. or (ii) a spiral wound organic membrane having a porosity of 0.10-0.35 micrometer at a volume concentration factor of 5-7 and temperature between 10 and 25° C. or 40 to 70° C., resulting in a retentate (MFR2) and a permeate (MFP2);
(b) ultrafiltering a liquid composition from the MFP2 over a membrane having a molecular weight cut-off of at most 25 kDa at a volume concentration factor of 4-6, resulting in a retentate (UFR) and a permeate (UFP);
(c) mixing a composition from the MFR2 and the UFR,
whereby a composition having a casein/whey weight ratio of 30/70-50/50 is obtained,
wherein the animal skim milk is a permeate (MFP1) from a microfiltration step (MF1) over a membrane having a porosity of 1.0-2.0 micrometer, at a volume concentration factor of 5-20, performed between 10° C. and 70° C., resulting in, a retentate (MFR1) and a permeate (MFP1),
wherein the process does not comprise electrodialysis or ion exchange.

2. The process according to claim 1 , wherein step (b) is not combined with diafiltration.

3. The process according to claim 1 , wherein the composition from the MFR2 and the composition originating from the UFR have, each individually, a water content of at least 60 wt %, based on their respective total weights, prior to step (c).

4. The process according to claim 1 , not comprising a spray-drying step prior to step (c).

5. The process according to claim 1 , wherein the temperature does not exceed 75° C. prior to step (c).

6. The process according to claim 5 , wherein the temperature does not exceed 60° C. prior to step (c).

7. The process according to claim 1 , further comprising nanofiltering a liquid composition front the UFR over a membrane having a molecular weight cut-off of at most 500 Da, resulting in a retentate (NFR) comprising whey and a permeate (NFP), wherein a liquid composition originating from the NFR is used in step (c).

8. The process according to claim 1 , comprising supplementing the UFR of step (b) with one or more of a fat source, a lactose source and a calcium source.

9. The process according to claim 1 , further comprising spray-drying the composition after step (c).

10. The process according to claim 1 , wherein:
(a) retentate (MFR2) comprises at most 15 wt % whey protein based on total protein and at least 55 wt % casein based on dry weight of the MFR2, and a permeate (MFP2) comprises at most 1.0 wt % casein based on total dry weight of the MFP2; and
(b) (UFR) comprises 22-33 wt % whey proteins based on total dry weight and a phosphorus/protein weight ratio between 1/40 and 1/100.

11. The process according to claim 1 , wherein the liquid composition subjected to ultrafiltering is directly obtained from the MFP2, optionally after concentration and/or supplementation of water or other components.

12. The process according to claim 1 , wherein the microfiltering of step (a) is performed at temperature between 10-25° C.

13. The process according to claim 1 , wherein the microfiltering of step (a) is performed at temperature between 40-60° C.

14. The process according to claim 1 , which does not require supplementation of Na, K, Cl, Mg and P to bring their respective amounts in the infant formula to the following ranges:

Na
120-180
mg/100 g

K
470-700
mg/100 g

Cl
300-450
mg/100 g

Mg
37-55
mg/100 g

P
185-280
mg/100 g.

15. The process according to claim 14 , wherein the infant formula comprises, per 100 g or dry matter: 11.2-12.5 g protein, 48.8-59.6 g lactose, and 27.9-30.8 g fat.

16. The process according, to claim 1 , wherein MF1 is over a membrane having a porosity of 1.0-2.0 micrometer, at a volume concentration factor of 8-15, performed between 25° C. and 65° C.

17. The process according to claim 1 , which is for humanizing animal milk.

Assignees

• Tobin John
• Kelly Philip
• Verdurmen Rudolph Eduardus Maria
• Van Baalen Antonie
• Van Eerten Roeland
• Nutricia Nv

Inventors

• Tobin John
• Kelly Philip
• Verdurmen Rudolph Eduardus Maria
• Van Baalen Antonie
• Van Eerten Roeland

Classifications

• A23J3/10

  Casein (drying casein A23J1/22) · CPC title

• A23J1/20

  from milk, e.g. casein (curds or cheese A23C); from whey · CPC title

• A23J3/08 Primary

  Dairy proteins · CPC title

• A23C9/1512

  containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate · CPC title

• A23C2210/206

  Membrane filtration of a permeate obtained by ultrafiltration, nanofiltration or microfiltration · CPC title